| 1 |
34587239 | t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. | 2022 Jan 8 |
1 |
| 2 |
32279331 | Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. | 2020 Jul |
1 |
| 3 |
30948162 | Eosinophilia in acute myeloid leukemia: Overlooked and underexamined. | 2019 Jul |
1 |
| 4 |
30168245 | A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings. | 2018 Dec |
1 |
| 5 |
28650474 | An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia. | 2017 Oct 26 |
1 |
| 6 |
27746819 | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature. | 2016 |
2 |
| 7 |
27812500 | An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL. | 2016 |
1 |
| 8 |
24975316 | Imatinib non-responsive chronic eosinophilic leukemia with ETV6-PDGFRA fusion gene. | 2015 Mar |
1 |
| 9 |
24053143 | Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review. | 2013 Sep 20 |
2 |
| 10 |
22634393 | CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737. | 2012 Sep |
1 |
| 11 |
20807977 | Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia. | 2010 Sep |
1 |
| 12 |
19135770 | Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors. | 2009 Mar |
1 |
| 13 |
19480935 | Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia. | 2009 Jul |
1 |
| 14 |
18615681 | Chronic phase of ETV6-ABL1 positive CML responds to imatinib. | 2008 Oct |
1 |
| 15 |
18656692 | Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement. | 2008 Aug |
1 |
| 16 |
17122866 | Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy. | 2007 Jan |
1 |
| 17 |
17508004 | A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease. | 2007 Aug |
1 |
| 18 |
16030188 | The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo. | 2005 Nov 1 |
1 |
| 19 |
16430106 | [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia]. | 2005 Dec |
1 |
| 20 |
15199413 | Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin. | 2004 Jun |
1 |
| 21 |
12681968 | Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia. | 2003 Apr |
3 |
| 22 |
12823349 | Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. | 2003 Jul |
2 |
| 23 |
11964320 | Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation. | 2002 May 1 |
2 |
| 24 |
10828035 | Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. | 2000 Jun 1 |
2 |